drugset / Trial / NCT01291511
Relapse Prevention Study in Patients With Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Iloperidone is effective in the prevention of relapse in patients with schizophrenia
Timeline
- Start
- 2011-02
- Primary completion
- 2014-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloperidone | Small molecule | 12 mg | Oral |